If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...

The use of thrombectomy in patients with acute stroke and a large infarct of unrestricted size has not been well studied. We assigned, in a 1:1 ratio, patients with proximal cerebral vessel occlusion ...

Perth-based biotech Argenica Therapeutics, which is developing treatments to reduce brain tissue death after stroke, plans to ...

The TESLA trial was unable to support a benefit to thrombectomy for stroke patients with large-core infarcts identified on noncontrast CT within 24 hours. Unlike other studies, endovascular therapy in ...

HELSINKI, Finland—Adding IV tirofiban improves functional outcomes among patients undergoing systemic thrombolysis for acute ischemic stroke within 4.5 hours of symptom onset, results from the ...

The effect of a liberal red-cell transfusion strategy as compared with a restrictive strategy in patients during the critical care period after an aneurysmal subarachnoid hemorrhage is unclear. We ...

Recovery after aneurysmal subarachnoid hemorrhage (aSAH) is widely believed to plateau within the first year, especially among those with severe initial disability. However, few large-scale, long-term ...